Solid Biosciences Announces Closing of Acquisition of AavantiBio and Concurrent $75 Million Private Placement Read more
AbCellera and Rallybio Announce Strategic Alliance to Discover, Develop, and Commercialize Novel Antibody-Based Therapeutics for Rare Diseases Read more
European Medicines Agency accepts marketing authorisation application for momelotinib for the treatment of myelofibrosis Read more
Immunocore and Gadeta Announce Agreement to Develop First Gamma Delta (γδ) TCR ImmTAC for Solid Tumors Read more
Brazilian Regulatory Authority Grants Approval for Waylivra™ for Familial Partial Lipodystrophy Read more
Incyte and CMS Announce Collaboration and License Agreement for Ruxolitinib Cream in Greater China and Southeast Asia Read more
AbCellera and Rallybio Announce Strategic Alliance to Discover, Develop, and Commercialize Novel Antibody-Based Therapeutics for Rare Diseases Read more